Iantrek is excited to announce our participation in the upcoming AAO event. We’re bringing you two captivating presentations.
1️⃣ DUAL PATHWAY MIGS: Get ready to explore the future of eye surgery with our in-depth look at Dual Pathway Minimally Invasive Glaucoma Surgery (MIGS).
2️⃣ 12-Month ALLOPASS Results: We’re proud to share the 12-month postoperative outcomes from the cases in Panama where our CycloPen System has been used for creation of a cyclodialysis cleft and delivery of minimally modified homologous biotissue for cleft maintenance and reinforcement.
#Iantrek #AAOEvent #Ophthalmology #EyeCare #Innovation #MIGS #ALLOPASS #Eyenovation
